Emerging concepts of T cell metabolism as a target of immunotherapy

Nature Immunology

Volumn 17, Issue 4, 2016, Pages 364-368

  Chang, Chih Hao ^a   Pearce, Erika L ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FUNCTION; CELL METABOLISM; HUMAN; IMMUNOTHERAPY; LONGEVITY; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ADOPTIVE IMMUNOTHERAPY; ANIMAL; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; GLYCOLYSIS; IMMUNOLOGY; METABOLISM; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TARGET OF RAPAMYCIN KINASE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; GLYCOLYSIS; HUMANS; IMMUNOTHERAPY; IMMUNOTHERAPY, ADOPTIVE; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES; TUMOR MICROENVIRONMENT;

EID: 84961736633     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3415     Document Type: Review

References (62)

1. Buck, M.D., O'Sullivan, D. & Pearce, E.L. T cell metabolism drives immunity. J. Exp. Med. 212, 1345-1360 (2015
2. O'Sullivan, D. & Pearce, E.L. Targeting T cell metabolism for therapy. Trends Immunol. 36, 71-80 (2015
3. Waickman, A.T. & Powell, J.D. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol. Rev. 249, 43-58 (2012
4. Michalek, R.D., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299-3303 (2011
5. Jacobs, S.R., et al. Glucose uptake is limiting in T cell activation and requires CD28- mediated Akt-dependent and independent pathways. J. Immunol. 180, 4476-4486 (2008
6. Cham, C.M. & Gajewski, T.F. Glucose availability regulates IFN-g production and p70S6 kinase activation in CD8+ effector T cells. J. Immunol. 174, 4670-4677 (2005
7. Chang, C.H., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239-1251 (2013
8. Doedens, A.L., et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 14, 1173-1182 (2013
9. Shi, L.Z., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376 (2011
10. Wang, R., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882 (2011
11. Villena, J.A. & Kralli, A. ERRa: a metabolic function for the oldest orphan. Trends Endocrinol. Metab. 19, 269-276 (2008
12. Michalek, R.D., et al. Estrogen-related receptor-A is a metabolic regulator of effector T-cell activation and differentiation. Proc. Natl. Acad. Sci. USA 108, 18348-18353 (2011
13. Man, K., et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14, 1155-1165 (2013
14. Yao, S., et al. Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation. Immunity 39, 833-845 (2013
15. MacIver, N.J., et al. The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J. Immunol. 187, 4187-4198 (2011
16. Chang, C.H., et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229-1241 (2015
17. Ho, P.C., et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162, 1217-1228 (2015
18. Blagih, J., et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42, 41-54 (2015
19. Mayer, A., Denanglaire, S., Viollet, B., Leo, O. & Andris, F. AMP-Activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. Eur. J. Immunol. 38, 948-956 (2008
20. Berod, L., et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327-1333 (2014
21. Ananieva, E.A., Patel, C.H., Drake, C.H., Powell, J.D. & Hutson, S.M. Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells. J. Biol. Chem. 289, 18793-18804 (2014
22. Lee, J., et al. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J. Immunol. 192, 3190-3199 (2014
23. Fischer, K., et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109, 3812-3819 (2007
24. Haas, R., et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 13, e1002202 (2015
25. Munn, D.H., et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase. Immunity 22, 633-642 (2005
26. Opitz, C.A., et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197-203 (2011
27. Mezrich, J.D., et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190-3198 (2010
28. Sharma, M.D., et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase. J. Clin. Invest. 117, 2570-2582 (2007
29. Pearce, E.L., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103-107 (2009
30. Araki, K., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112 (2009
31. van der Windt, G.J., et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68-78 (2012
32. Rolf, J., et al. AMPKa1: a glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 43, 889-896 (2013
33. van der Windt, G.J., et al. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. Proc. Natl. Acad. Sci. USA 110, 14336-14341 (2013
34. Fraser, K.A., Schenkel, J.M., Jameson, S.C., Vezys, V. & Masopust, D. Preexisting high frequencies of memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting. Immunity 39, 171-183 (2013
35. O'Sullivan, D., et al. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41, 75-88 (2014
36. Cui, G., et al. IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T Cell longevity. Cell 161, 750-761 (2015
37. Maekawa, Y., et al. Notch controls the survival of memory CD4+ T cells by regulating glucose uptake. Nat. Med. 21, 55-61 (2015
38. Wang, Y., Wang, X.Y., Subjeck, J.R., Shrikant, P.A. & Kim, H.L. Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines. Br. J. Cancer 104, 643-652 (2011
39. Chaoul, N., et al. Rapamycin impairs antitumor CD8+ T-cell responses and vaccine-induced tumor eradication. Cancer Res. 75, 3279-3291 (2015
40. Gattinoni, L., Klebanoff, C.A. & Restifo, N.P. Pharmacologic induction of CD8+ T cell memory: better living through chemistry. Sci. Transl. Med. 1, 11ps12 (2009
41. Patsoukis, N., et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6, 6692 (2015
42. Calvaresi, E.C., et al. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor. ChemBioChem 14, 2263-2267 (2013
43. Lameris, R., et al. Bispecific antibody platforms for cancer immunotherapy. Crit. Rev. Oncol. Hematol. 92, 153-165 (2014
44. Mundra, V., Li, W. & Mahato, R.I. Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (Lond.) 10, 2613-2633 (2015
45. Gerriets, V.A., et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194-207 (2015
46. Sinclair, L.V., et al. Control of amino-Acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500-508 (2013
47. Maus, M.V., et al. Adoptive immunotherapy for cancer or viruses. Annu. Rev. Immunol. 32, 189-225 (2014
48. Sukumar, M., et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123, 4479-4488 (2013
49. Sukumar, M., et al. Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy. Cell Metab. 23, 63-76 (2015
50. Simpson, T.R., et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti CTLA-4 therapy against melanoma. J. Exp. Med. 210, 1695-1710 (2015
51. Nakahashi-Oda, C., et al. Nat. Immunol. 17, 441-450 (2016
52. Zenarruzabeitia, O., Vitallé, J., Eguizabal, C., Simhadri, V.R. & Borrego, F. J. Immunol. 194, 5053-5060 (2015
53. Kole, A., et al. J. Immunol. 191, 2771-2779 (2013
54. Metidji, A., et al. J. Immunol. 194, 4265-4276 (2015
55. Tanaka, T., et al. Sci. Rep. 4, 5412 (2014
56. Torchinsky, M.B., Garaude, J., Martin, A.P. & Blander, J.M. Nature 458, 78-82 (2009
57. Nenci, A., et al. Nature 446, 557-561 (2007
58. Dannappel, M., et al. Nature 513, 90-94 (2014
59. Cerovic, V., Bain, C.C., Mowat, A.M. & Milling, S.w. Trends Immunol. 35, 270-277 (2014
60. Ohnmacht, C., et al. Science 349, 989-993 (2015
61. Sefik, E., et al. Science 349, 993-997 (2015
62. Arpaia, N., et al. Cell 162, 1078-1089 (2015